As of October 2025, Asian markets have shown resilience, with significant gains in technology-focused shares and an overall positive sentiment despite some economic challenges. For investors looking to explore opportunities beyond the major indices, penny stocks remain a compelling area of interest. Although the term “penny stocks” may seem outdated, it continues to represent smaller or newer companies that can offer unique growth potential when backed by strong financials and strategic direction.
Name
Share Price
Market Cap
Financial Health Rating
JBM (Healthcare) (SEHK:2161)
HK$2.97
HK$2.42B
★★★★★★
Lever Style (SEHK:1346)
HK$1.51
HK$933.97M
★★★★★★
Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)
Click here to see the full list of 952 stocks from our Asian Penny Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: LifeTech Scientific Corporation is an investment holding company that develops, manufactures, and trades interventional medical devices for cardiovascular and peripheral vascular diseases globally, with a market cap of HK$9.87 billion.
Operations: The company’s revenue is derived from its Structural Heart Diseases Business (CN¥527.87 million), Peripheral Vascular Diseases Business (CN¥762.08 million), and Cardiac Pacing and Electrophysiology Business (CN¥37.63 million).
Market Cap: HK$9.87B
LifeTech Scientific’s financial health is bolstered by its short-term assets of CN¥2.6 billion, which comfortably cover both short and long-term liabilities, indicating strong liquidity. Despite a significant one-off loss impacting recent earnings, the company remains debt-free, alleviating concerns over interest coverage. However, profitability has declined with net profit margins dropping to 5.4% from 19.4% last year. Recent approval for an innovative congenital heart defect occluder could enhance its product portfolio and market position in medical devices, potentially offsetting negative earnings growth trends observed over the past year and five years respectively.
SEHK:1302 Financial Position Analysis as at Oct 2025
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Youzan Technology Limited is an investment holding company that offers e-commerce solutions both online and offline in China, Japan, and Canada, with a market cap of HK$6.28 billion.
Operations: The company generates revenue from its operations in Japan, amounting to CN¥0.61 million.
Market Cap: HK$6.28B
Youzan Technology has shown a significant turnaround by reporting a net income of CN¥72.74 million for the first half of 2025, compared to a loss in the previous year, driven by increased revenue and operational efficiency. The company’s liquidity is robust, with short-term assets exceeding both short and long-term liabilities. Despite past volatility in its share price, Youzan’s strategic buyback of over 331 million shares reflects confidence in its valuation. While still unprofitable on an annual basis, it maintains a positive cash flow with enough runway for over three years, supported by experienced management and board members.
SEHK:8083 Financial Position Analysis as at Oct 2025
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: CSE Global Limited is an investment holding company that provides integrated industrial automation, information technology, and intelligent transport solutions across various regions including the Asia Pacific, the Americas, Europe, the Middle East, and Africa; it has a market cap of SGD561.01 million.
Operations: The company generates revenue from three primary segments: Automation (SGD193.85 million), Communications (SGD246.50 million), and Electrification (SGD432.82 million).
Market Cap: SGD561.01M
CSE Global Limited’s financial health is supported by strong liquidity, with short-term assets of SGD390.1 million exceeding both short-term and long-term liabilities. The company’s earnings have shown modest growth, with net income rising to SGD16.3 million for the first half of 2025, up from SGD15.02 million a year ago. Despite this growth, operating cash flow remains negative, raising concerns about debt coverage. Recent contract wins in the U.S., valued at approximately S$59.3 million, highlight potential revenue expansion opportunities in the data centre market. However, dividend sustainability is questionable due to insufficient free cash flows covering payouts.
SGX:544 Financial Position Analysis as at Oct 2025
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SEHK:1302 SEHK:8083 and SGX:544.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Oscar Piastri has admitted he’s had to “drive the car very differently these last couple of weekends” after finishing fifth in the Mexico City Grand Prix and losing the Drivers’ Championship lead to McLaren team mate Lando Norris.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Akbank TAS (AKBTY) reported a 17% year-on-year increase in net income, reaching 38,908 million, with a return on equity (ROE) of 20.4%.
The bank achieved a 48% year-on-year growth in revenue, driven by robust fee generation and renewed net interest income (NII) momentum.
Akbank TAS (AKBTY) captured 90 basis points of market share in business banking loans among private banks, demonstrating targeted focus on growth segments.
The bank’s securities portfolio showed a balanced approach with a focus on yield maximization, achieving a 21% year-to-date growth in foreign currency securities.
Akbank TAS (AKBTY) maintained a strong capital position with total capital, tier one, and core equity tier one ratios at 17.2%, 13.6%, and 12.4%, respectively.
The anticipated margin expansion was postponed due to strong monetary tightening in April.
Economic activity showed signs of moderation in Q3, with mild economic growth expected for the year.
The bank’s Turkish time deposit market share fell short due to funding optimization efforts and regulation-driven low levels of Turkish RDR.
The net cost of credit increased to 230 basis points, driven by ongoing retail NPL inflows and strengthening coverage ratios.
The bank’s full-year cost of credit may slightly exceed the upper end of the guidance range of 150 to 200 basis points.
Q: Could you elaborate on the strong margin expansion in Q3 and expectations for Q4 and beyond? A: (Turk) The strong recovery in Q3 was mainly due to deposit cost easing, aligning with our expectations. However, the latest rate cut in September wasn’t fully reflected in deposit pricing. As we enter Q4, the net interest margin is expected to start above Q3 levels, but the extent of improvement will depend on future rate cuts. We anticipate gradual margin improvement throughout 2026 rather than a peak early in the year.
Q: How do you see the full-year outlook evolving, considering the 25% ROE target and recent macro changes? A: (Turk) Achieving the 25% ROE target may be challenging due to the delay in the rate cut cycle. We now expect the policy rate to be around 38% by year-end, impacting our exit NIM. However, we anticipate a gradual improvement in NIM next year, with ROE likely ending between the current level and the 25% target.
Q: What factors could lead to a deceleration in fee income growth, and how are restructured loans impacting your strategy? A: (Turk) Fee income growth remains strong, driven by customer acquisition and engagement. Regulatory changes on debit cards will impact Q4, but the effect is moderate. We aim to maintain a high fee-to-OpEx ratio. The increase in restructured loans is mainly due to a BRSA scheme for credit card customers, but our overall restructured loan ratio remains low.
Q: Can you explain the recent increase in retail FX deposits and any stress tests conducted on loan quality? A: (Turgar) The increase in FX deposits is mainly due to parity changes, particularly in gold deposits. There’s no significant shift from TL to FX deposits. We regularly conduct stress tests, and our capital remains strong under various scenarios. We continuously adjust lending criteria based on sector performance.
Q: Do you have a cost of risk estimate for 2026? A: (Turgar) We are currently in the budgeting process and will provide guidance by the end of January. However, we expect the cost of risk to evolve at similar levels to 2025.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
As the film began, a quiet gasp of awe rippled through the audience. When the screen illuminated the dark theater, every frame came to life with an unprecedented level of clarity. The characters’ subtle expressions were…
New findings from Ontario’s largest birth cohort reveal that sulfate and ammonium particles in fine air pollution may disrupt fetal brain development, highlighting the need for cleaner air in urban and disadvantaged communities.
Unfortunately, you can’t add bots in Counter-Strike 1.6 out of the box. The game simply arrived too early for that, and bots would only make their debut in CS: Source. But gamers are resourceful, and so players over the years have…
U.S. stocks signaled another rally on Sunday night after the Trump administration negotiated a framework for a trade deal with China that should avoid mutual assured destruction.
Treasury Secretary Scott Bessent offered rough outlines of an agreement that include China easing rare earth export restrictions and buying “significant” amounts of U.S. soybeans in exchange for President Donald Trump removing his threat of adding 100% tariffs on China.
Trump and Chinese President Xi Jinping are scheduled to meet Thursday on the sidelines of a regional economic conference in South Korea, where they will determine the final details of a deal.
Futures tied to the Dow Jones industrial average rose 312 points, or 0.66%. S&P 500 futures were up 0.75%, and Nasdaq futures added 0.91%. That would add to Friday’s rally that saw fresh record highs.
The yield on the 10-year Treasury was flat at 4.003%. The U.S. dollar was down 0.03% against the euro and up 0.16% against the yen.
Gold fell 0.59% to $4,113.40 per ounce. U.S. oil futures rose 0.80% to $61.99 a barrel, and Brent crude climbed 0.76% to $66.44.
Wall Street is also looking ahead to the Federal Reserve’s policy meeting, which will conclude on Wednesday. Investors overwhelmingly expect another quarter-point rate cut, bringing the benchmark rate to 3.75%-4.00%.
That’s after the consumer price index for September inched up but came in below forecasts, clearing the way for the Fed to focus more on the maximum-employment side of its mandate than the inflation-fighting side.
The coming week will also be busy for tech earnings amid growing concerns that the AI boom may be starting to resemble a bubble.
Meta, Microsoft and Google parent Alphabet report on Wednesday, while Apple and Amazon report on Thursday.
The question over what involvement Cummins may have and the bowlers Australia could use fuels the suspicion that pace bowling will be a determining factor in the eventual Ashes winners.
England have named a battery of quick bowlers in their squad,…
